1464154-07-1 Usage
Uses
Used in Pharmaceutical Research:
(3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)(4-methylpiperazin-1-yl)methanone is used as a research compound for the development of new pharmaceutical drugs, leveraging the piperazine moiety that is commonly found in many medications.
Used in Organic Synthesis:
In the field of organic chemistry, (3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)(4-methylpiperazin-1-yl)methanone is used as a reagent for the formation of carbon-carbon and carbon-heteroatom bonds, thanks to the dioxaborolane group that plays a crucial role in such reactions.
(Note: The specific applications and uses mentioned are hypothetical and provided as examples based on the general properties of the compound's constituent groups. Further research and investigation would be necessary to confirm the actual applications and uses of (3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)(4-methylpiperazin-1-yl)methanone.)
Check Digit Verification of cas no
The CAS Registry Mumber 1464154-07-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,6,4,1,5 and 4 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1464154-07:
(9*1)+(8*4)+(7*6)+(6*4)+(5*1)+(4*5)+(3*4)+(2*0)+(1*7)=151
151 % 10 = 1
So 1464154-07-1 is a valid CAS Registry Number.
1464154-07-1Relevant academic research and scientific papers
BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF
-
, (2015/01/06)
The present invention relates to certain compounds (e.g., imidazopyrazine, imidazopyridine, imidazopyridazine and imidazpyrimidine compounds) that act as inhibitors of the MAP kinase interacting kinases MNK2a, MNK2b, MNK1a, and MNK1b. The present invention further relates to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of diseases (e.g., proliferative diseases (e.g., cancer), inflammatory diseases, Alzheimer's disease), as well as methods of treating these diseases.
BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF
-
, (2013/10/21)
The present invention relates to certain compounds (e.g., imidazopyrazine, imidazopyridine, imidazopyridazine and imidazpyrimidine compounds) that act as inhibitors of the MAP kinase interacting kinases MNK2a, MNK2b, MNK1a, and MNK1b. The present invention further relates to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of diseases (e.g., proliferative diseases (e.g., cancer), inflammatory diseases, Alzheimer's disease), as well as methods of treating these diseases
